- Home
- NL vs OCGN Comparison
NL vs OCGN Comparison
Compare NL & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- OCGN
- Stock Information
- Founded
- NL 1891
- OCGN 2013
- Country
- NL United States
- OCGN United States
- Employees
- NL N/A
- OCGN N/A
- Industry
- NL Major Chemicals
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NL Industrials
- OCGN Health Care
- Exchange
- NL Nasdaq
- OCGN Nasdaq
- Market Cap
- NL 316.5M
- OCGN 283.3M
- IPO Year
- NL N/A
- OCGN N/A
- Fundamental
- Price
- NL $6.64
- OCGN $1.12
- Analyst Decision
- NL Sell
- OCGN Strong Buy
- Analyst Count
- NL 1
- OCGN 3
- Target Price
- NL $6.00
- OCGN $6.00
- AVG Volume (30 Days)
- NL 41.3K
- OCGN 6.8M
- Earning Date
- NL 08-06-2025
- OCGN 08-01-2025
- Dividend Yield
- NL 5.50%
- OCGN N/A
- EPS Growth
- NL 441.25
- OCGN N/A
- EPS
- NL 1.25
- OCGN N/A
- Revenue
- NL $148,242,000.00
- OCGN $4,522,000.00
- Revenue This Year
- NL $15.75
- OCGN N/A
- Revenue Next Year
- NL $2.44
- OCGN N/A
- P/E Ratio
- NL $5.38
- OCGN N/A
- Revenue Growth
- NL N/A
- OCGN N/A
- 52 Week Low
- NL $5.21
- OCGN $0.52
- 52 Week High
- NL $9.42
- OCGN $1.70
- Technical
- Relative Strength Index (RSI)
- NL 50.46
- OCGN 57.88
- Support Level
- NL $6.35
- OCGN $0.99
- Resistance Level
- NL $6.78
- OCGN $1.06
- Average True Range (ATR)
- NL 0.35
- OCGN 0.08
- MACD
- NL 0.05
- OCGN 0.00
- Stochastic Oscillator
- NL 64.29
- OCGN 75.09
About NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").